These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36005384)

  • 21. Alzheimer's disease: The influence of age on clinical heterogeneity through the human brain connectome.
    Dickerson BC; Brickhouse M; McGinnis S; Wolk DA
    Alzheimers Dement (Amst); 2017; 6():122-135. PubMed ID: 28239637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of ApoE genotype on clinical phenotypes in early-onset and late-onset Alzheimer's disease in China: Data from the PUMCH dementia cohort.
    Dong L; Li J; Liu C; Mao C; Wang J; Lei D; Huang X; Chu S; Hou B; Feng F; Sha L; Xu Q; Gao J
    Brain Behav; 2021 Nov; 11(11):e2373. PubMed ID: 34555265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medial temporal atrophy in early and late-onset Alzheimer's disease.
    Cavedo E; Pievani M; Boccardi M; Galluzzi S; Bocchetta M; Bonetti M; Thompson PM; Frisoni GB
    Neurobiol Aging; 2014 Sep; 35(9):2004-12. PubMed ID: 24721821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional connectivity changes differ in early and late-onset Alzheimer's disease.
    Gour N; Felician O; Didic M; Koric L; Gueriot C; Chanoine V; Confort-Gouny S; Guye M; Ceccaldi M; Ranjeva JP
    Hum Brain Mapp; 2014 Jul; 35(7):2978-94. PubMed ID: 24123475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Subcortical Structural Shapes With Tau, Amyloid, and Cortical Atrophy in Early-Onset and Late-Onset Alzheimer's Disease.
    Lee EC; Kang JM; Seo S; Seo HE; Lee SY; Park KH; Na DL; Noh Y; Seong JK
    Front Aging Neurosci; 2020; 12():563559. PubMed ID: 33192457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative MRI Differences Between Early versus Late Onset Alzheimer's Disease.
    Meysami S; Raji CA; Merrill DA; Porter VR; Mendez MF
    Am J Alzheimers Dis Other Demen; 2021; 36():15333175211055325. PubMed ID: 34814740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. White matter atrophy in Alzheimer's disease variants.
    Migliaccio R; Agosta F; Possin KL; Rabinovici GD; Miller BL; Gorno-Tempini ML
    Alzheimers Dement; 2012 Oct; 8(5 Suppl):S78-87.e1-2. PubMed ID: 23021625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regional cortical thinning and cerebrospinal biomarkers predict worsening daily functioning across the Alzheimer's disease spectrum.
    Marshall GA; Lorius N; Locascio JJ; Hyman BT; Rentz DM; Johnson KA; Sperling RA
    J Alzheimers Dis; 2014; 41(3):719-28. PubMed ID: 24685624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebrospinal fluid biomarkers for Alzheimer's disease: the role of apolipoprotein E genotype, age, and sex.
    Mehrabian S; Alexopoulos P; Ortner M; Traykov L; Grimmer T; Kurz A; Förstl H; Bickel H; Diehl-Schmid J
    Neuropsychiatr Dis Treat; 2015; 11():3105-10. PubMed ID: 26719695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebrospinal fluid biomarkers and cerebral atrophy in distinct clinical variants of probable Alzheimer's disease.
    Ossenkoppele R; Mattsson N; Teunissen CE; Barkhof F; Pijnenburg Y; Scheltens P; van der Flier WM; Rabinovici GD
    Neurobiol Aging; 2015 Aug; 36(8):2340-7. PubMed ID: 25990306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiation of neuropsychological features between posterior cortical atrophy and early onset Alzheimer's disease.
    Li J; Wu L; Tang Y; Zhou A; Wang F; Xing Y; Jia J
    BMC Neurol; 2018 May; 18(1):65. PubMed ID: 29747584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal changes of cortical thickness in early- versus late-onset Alzheimer's disease.
    Cho H; Jeon S; Kang SJ; Lee JM; Lee JH; Kim GH; Shin JS; Kim CH; Noh Y; Im K; Kim ST; Chin J; Seo SW; Na DL
    Neurobiol Aging; 2013 Jul; 34(7):1921.e9-1921.e15. PubMed ID: 23391426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurofilament light as a biomarker of axonal degeneration in patients with mild cognitive impairment and Alzheimer's disease.
    Chen Y; Therriault J; Luo J; Ba M; Zhang H; Initiative ADN
    J Integr Neurosci; 2021 Dec; 20(4):861-870. PubMed ID: 34997710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of different MRI-based morphometric estimates for defining neurodegeneration across the Alzheimer's disease continuum.
    Allison SL; Koscik RL; Cary RP; Jonaitis EM; Rowley HA; Chin NA; Zetterberg H; Blennow K; Carlsson CM; Asthana S; Bendlin BB; Johnson SC
    Neuroimage Clin; 2019; 23():101895. PubMed ID: 31252287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrospinal fluid biomarkers in clinical subtypes of early-onset Alzheimer's disease.
    Teng E; Yamasaki TR; Tran M; Hsiao JJ; Sultzer DL; Mendez MF
    Dement Geriatr Cogn Disord; 2014; 37(5-6):307-14. PubMed ID: 24401901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microglial Activation, Tau Pathology, and Neurodegeneration Biomarkers Predict Longitudinal Cognitive Decline in Alzheimer's Disease Continuum.
    Chen YH; Lin RR; Huang HF; Xue YY; Tao QQ
    Front Aging Neurosci; 2022; 14():848180. PubMed ID: 35847667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mapping the Progression of Atrophy in Early- and Late-Onset Alzheimer's Disease.
    Migliaccio R; Agosta F; Possin KL; Canu E; Filippi M; Rabinovici GD; Rosen HJ; Miller BL; Gorno-Tempini ML
    J Alzheimers Dis; 2015; 46(2):351-64. PubMed ID: 25737041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease.
    Jack CR; Wiste HJ; Vemuri P; Weigand SD; Senjem ML; Zeng G; Bernstein MA; Gunter JL; Pankratz VS; Aisen PS; Weiner MW; Petersen RC; Shaw LM; Trojanowski JQ; Knopman DS;
    Brain; 2010 Nov; 133(11):3336-48. PubMed ID: 20935035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Similar pattern of atrophy in early- and late-onset Alzheimer's disease.
    Eckerström C; Klasson N; Olsson E; Selnes P; Rolstad S; Wallin A
    Alzheimers Dement (Amst); 2018; 10():253-259. PubMed ID: 29780870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.